We are a next-generation
biopharmaceutical company with a unique two-pronged business
model to rapidly design, develop, and commercialize innovative,
safe, and effective products for the global Consumer Health Care (CHC) and Prescription (Rx) markets. Our product and business strategies have substantial time
and cost advantages as compared to chemical entity-based healthcare products.
We have strong products and product pipelines targeting:
- Respiratory disorders (>$15BN USD market)
- Diabetes and metabolic disorders (>$25BN USD market)
- Stress and women's health (>$8BN USD market)
We are currently seeking to expand our partnerships with alliances who share our
vision and commitment and compliment our skills and current resources. We offer substantial value to potential
partners for establishing "win-win" collaborations. |